Meihua International Medical Technologies Co annual debt-to-ebitda ratio
2020
2021
2022
2023
2024
2025
Meihua International Medical Technologies Co Debt-to-EBITDA Ratio Growth & History (MHUAF)
Meihua International Medical Technologies Co's debt-to-ebitda ratio was 1.02 for fiscal 2025.
View full Meihua International Medical Technologies Co company overviewMeihua International Medical Technologies Co annual debt-to-ebitda ratio history
| Fiscal year | Period ended | Debt-to-EBITDA ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 1.02 | 0.48 | +90.56% |
| 2024 | 2024-12-31 | 0.53 | 0.05 | +10.30% |
| 2023 | 2023-12-31 | 0.48 | −0.12 | −19.42% |
| 2022 · Dec 31 | 2022-12-31 | 0.60 | 0.41 | +211.56% |
| 2021 | 2021-12-31 | 0.19 | 0.06 | +43.57% |
| 2020 | 2020-12-31 | 0.13 | — | — |
Meihua International Medical Technologies Co debt-to-ebitda ratio trends
Over the last five fiscal years, Meihua International Medical Technologies Co's debt-to-ebitda ratio increased from 0.13 to 1.02, a change of 0.88.
About the metric
What the debt-to-EBITDA ratio means
Debt-to-EBITDA compares interest-bearing debt with operating earnings before interest, taxes, depreciation, and amortization. It is commonly used to assess leverage, but it is generally unsuitable for banks and other financial companies.
Calculation and source
How debt-to-EBITDA is calculated
TickerStat divides period-end total debt by annual EBITDA. Quarterly observations use trailing-12-month EBITDA. Periods with zero or negative EBITDA are excluded because the leverage multiple would not be meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Meihua International Medical Technologies Co source filings ↗